Last Week’s Hot Topic on Pulmonary Fibrosis



Last week’s hot topic on pulmonary fibrosis was OFEV’s Effectiveness as IPF Treatment Confirmed in Analysis of Pooled Clinical Trial Data written by Margarida Azevedo.

This article is about combined evidence from the TOMORROW and INPULSIS clinical trials that confirm the safety and efficacy of OFEV (nintedanib, Boehringer Ingelheim) in slowing disease progression and greatly reducing acute exacerbations in patients with idiopathic pulmonary fibrosis (IPF), a study reported.

The article detailing the pooled analyses of the clinical studies, “Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials,” was published in the journal Respiratory Medicine.


Read the latest news on pulmonary fibrosis:

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *